The Transatlantic Trade and Investment Partnership (TTIP) aims to create more open trade between the EU and the U.S. Strengthening the world’s most important trading relationship can serve as a key platform to bring quicker new treatment options to patients. TTIP has the potential to facilitate the development of new medicines and improve health outcomes and support new long-term economic benefits.
Europe and the U.S. account for more than 75% of global R&D in life sciences and create and sustain over 1.5 million direct jobs.
How will TTIP benefit patients, science, healthcare systems, innovation, and the economy?